Sandoz and Roche settle dispute over rituximab biosimilar

Apr 11, 2019

Sandoz and Roche settle long-running AU Federal Court dispute over rituximab biosimilar, allowing for the launch of Sandoz product Riximyo® “in the near future”.  The 2017 Federal Court proceedings before Burnley J were dismissed.

Print Page Mail Article